ICU Medical CFO Brian Bonnell offloaded 6,381 shares in a scheduled 10b5-1 transaction, maintaining a significant $9.5 million equity position as the firm reports strong quarterly earnings growth.
CFO sold 6,381 shares under a pre-arranged 10b5-1 trading plan, maintaining 56,062 shares, indicating routine portfolio diversification rather than opportunistic selling.
ICU Medical CFO Brian Bonnell executed a pre-arranged sale of 6,381 shares on September 1, 2026, valued at approximately $1.1 million. The transaction, conducted under a Rule 10b5-1 trading plan, leaves the executive with a remaining direct stake of 56,062 shares worth $9.5 million, signaling routine portfolio management rather than a shift in company outlook.
The sale was part of a pre-arranged Rule 10b5-1 trading plan adopted in June 2026, which is a standard mechanism for insiders to sell stock without triggering concerns regarding material non-public information.